REMSleep Holdings, Inc. (RMSL) Research

REMSleep Holdings, Inc. is an enterprise globally focused on crafting and providing solutions for individuals afflicted with sleep apnea. Among its key offerings is the DeltaWave CPAP interface device, specifically engineered to aid in the treatment of patients suffering from this condition. The company caters to a broad spectrum of clients, including home healthcare providers, independent sleep clinics, direct consumers, medical practitioners, group medical organizations, hospitals, and various professional medical associations. Its corporate headquarters are situated in Tampa, Florida.

Market snapshot

Symbol
RMSL
Price
$0.00
Day change
-10.37%
Market cap
$4.1M
P/E ratio
-0.00x
52-week range
0.0012-0.0109
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Cardiac Biotech Solutions Inc. (CBSC)
  • Canntab Therapeutics Limited (CTABF)
  • Fuse Medical, Inc. (FZMD)
  • Interpace Biosciences, Inc. (IDXG)
  • IR-Med Inc. (IRME)
  • Metawells Oil & Gas Inc. (KOSK)
  • Lifeline Biotechnologies, Inc. (LLBO)
  • PD-Rx Pharmaceuticals, Inc. (PDRX)

Recent insider activity

  • BIRD RUSSELL FINLAY — trade (0 shares) on 2017-06-29
  • BIRD RUSSELL FINLAY — trade (1500000 shares) on 2017-06-29
  • WOOD TOM J — trade (0 shares) on 2017-06-29
  • WOOD TOM J — trade (2000000 shares) on 2017-06-29
  • Sullivan Matthew — trade (0 shares) on 2012-04-18

Open REMSleep Holdings, Inc. (RMSL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.